Kanagawa, Japan

Eri Ikuno

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eri Ikuno: Innovator in Embolic Agent Technology

Introduction

Eri Ikuno is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical technology, particularly in the development of embolic agents. With a total of 2 patents, Ikuno's work focuses on enhancing the visibility and effectiveness of embolic materials used in medical procedures.

Latest Patents

Ikuno's latest patents include an "Embolic Agent Kit" and "Embolus Material and Method of Manufacturing the Same." The embolic agent kit provides a technique capable of ensuring good visibility when introducing an embolic agent while reducing visibility after introduction. This kit includes a catheter with an inner cavity, a reaction product of an ethylenically unsaturated monomer and a crosslinking agent, and a priming solution containing a visualization agent. The second patent describes an embolic material that prevents the flow of biological fluid by being placed in a body lumen via a catheter. This material swells upon contact with biological fluid and includes a long filler that bends to prevent fluid flow.

Career Highlights

Eri Ikuno is currently employed at Terumo Kabushiki Kaisha, a leading company in the medical technology sector. His innovative work has contributed to advancements in medical procedures, particularly in the area of embolization.

Collaborations

Ikuno collaborates with Yuki Itoh, a talented woman in the field, who contributes to the development of their projects.

Conclusion

Eri Ikuno's contributions to embolic agent technology demonstrate his commitment to improving medical procedures. His innovative patents reflect a deep understanding of the challenges in the field and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…